Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related news and success stories.
-
24 Apr 2024
Success Case: GFT’s Experience in Barcelona-Catalonia
-
19 Apr 2024
Chinese company Chery chooses Barcelona for its first electric car plant in Europe
-
25 Mar 2024
French company K·Line invests 18 million euros in a new factory in Catalonia
-
20 Mar 2024
Boehringer Ingelheim, commited to Catalonia's Life Sciences talent